Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
122.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.50 (2.066%)
Market Cap: £194.77m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Board Changes

1 Nov 2024 07:00

RNS Number : 4424K
Redcentric PLC
01 November 2024
 

Redcentric plc

 

("Redcentric" or the "Group")

 

Board Changes

Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, confirms that further to the announcement on 24 September 2024, John Radziwill has been appointed as non-executive director of the Company after completing the relevant due diligence as part of the onboarding process for all new board appointments. Mr Radziwill joins the board as a representative of ND Capital Investments Limited ("ND Capital"), one of the Company's largest shareholders, and is a highly experienced director. Mr Radziwill has held several senior leadership roles in investment banking, advisory and asset management.

Relationship Agreement

In conjunction with Mr Radziwill's appointment, the Company has entered into a relationship agreement with ND Capital. The key terms of this agreement are as follows:

· ND Capital has the right to nominate one person for appointment as a director of the Company providing that ND Capital (together with its individual partners and their affiliates), directly or indirectly, holds no less than 15 per cent of the voting rights of the Company (or 7.5 per cent taking into account any reduction in voting rights resulting from any dilution following the date of the agreement);

· All transactions, agreements or arrangements entered into between a member of the Group and ND Capital and/or any of its associates will be conducted at arm's length and on arm's length commercial terms; 

· ND Capital shall exercise its voting rights to ensure, so far as it is able to do so by the exercise of such rights, that directors independent of ND Capital shall at all times constitute a majority of the Redcentric board (save with the approval of a majority of the independent directors);

· ND Capital and its associates will not propose any resolution or other action to cancel the trading of the Company's shares from trading on AIM without the board's approval (save with the approval of a majority of the independent directors); and

· ND Capital and its associates will not solicit proxies unless consistent with the recommendation of the board, exercise powers to requisition a shareholders' meeting, or undertake any action to obtain or consolidate control of the Company or seek to do so, otherwise than in accordance with the Takeover Code.

Richard McGuire, Chair of Redcentric, commented:

"John brings a wealth of expertise and experience to the Group. His addition further strengthens the Board composition and capabilities to drive execution of the Group's strategic initiatives. John represents one of the Company's long-standing and major investors through his role at ND Capital, and we look forward to his valuable insights and contributions in advancing Redcentric's strategy."

Additional information with regard to John Radziwill:

The following information is disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies:

Full name: John Stanislas Albert Radziwill

Age: 77

Current directorships:

StoneX Group Inc.

Oryx International Growth Fund Ltd.

Seatboost Inc.

GGH Management 2 Sp. z o. o.

GGH Management 3 Sp z o.o.

StoneX Switzerland SA

Netsurion LLC (formerly known as VendorSafe Technologies Inc.)

Furnari Sp.z.o.o.

Previous directorships held in the past 5 years:

GGH MT Sp. z o. o.

Fifth Street Capital (BVI)

 

Save as set out above there are no further disclosures required pursuant to Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies.

Enquiries:

Redcentric plc +44 (0)800 983 2522

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 

Cavendish Capital Markets Limited - Nomad and Sole Broker +44 (0)20 7220 0500

Marc Milmo / Callum Davidson / Rory Sale (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZMFGMMDGDZM
Date   Source Headline
5th Oct 20207:00 amRNSRestitution Scheme Update
1st Oct 20203:15 pmRNSForm 8.3 - Redcentric PLC
1st Oct 20207:00 amRNSRule 2.9 Announcement
1st Oct 20207:00 amRNSExercise of Options
28th Sep 20202:42 pmRNSForm 8.3 - Redcentric PLC
28th Sep 20207:00 amRNSRule 2.9 Announcement
28th Sep 20207:00 amRNSRestitution Scheme Update
25th Sep 20203:00 pmRNSForm 8.3 - Redcentric PLC
25th Sep 202010:21 amRNSForm 8.3 - Redcentric PLC
24th Sep 20202:49 pmRNSForm 8.3 - Redcentric PLC
23rd Sep 20202:45 pmRNSForm 8.3 - Redcentric PLC
17th Sep 20207:00 amRNSForm 8.3 - Redcentric plc
16th Sep 20202:49 pmRNSResult of AGM
16th Sep 202010:56 amRNSForm 8 (OPD) - SIX DEGREES HOLDINGS LIMITED
14th Sep 202011:30 amRNSRestitution Scheme Update
14th Sep 202011:30 amRNSRule 2.9 Announcement
14th Sep 20208:44 amRNSForm 8.3 - Redcentric Plc
9th Sep 20206:28 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:26 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:24 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:23 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:23 pmRNSForm 8.3 - Redcentric PLC
9th Sep 20206:22 pmRNSForm 8.3 - Redcentric PLC
7th Sep 202012:57 pmRNSGranite Growth 169 LLC Form 8.3 - Redcentric Plc
7th Sep 20207:00 amRNSForm 8 (OPD) - Redcentric plc
4th Sep 20204:37 pmRNSForm 8.3 - Redcentric PLC
4th Sep 20209:08 amRNSForm 8.3 - Redcentric Plc
4th Sep 20208:55 amRNSForm 8.3 - Redcentric Plc
3rd Sep 20205:35 pmRNSForm 8.3 - Redcentric Plc
3rd Sep 20204:41 pmRNSSecond Price Monitoring Extn
3rd Sep 20204:35 pmRNSPrice Monitoring Extension
3rd Sep 20204:33 pmRNSForm 8.3 - Redcentric plc
3rd Sep 20201:15 pmRNSForm 8 (OPD) - Redcentric PLC
3rd Sep 202012:00 pmRNSForm 8.5 (EPT/RI) - Redcentric Plc
3rd Sep 20209:07 amRNSForm 8.3 - Redcentric PLC
3rd Sep 20208:30 amRNSRule 2.9 Announcement
2nd Sep 20207:00 amRNSResponse to press speculation-formal sales process
1st Sep 20208:30 amRNSRestitution Scheme Update
1st Sep 20207:00 amRNSSave As You Earn Share Option Scheme
24th Aug 202010:23 amRNSRestitution Scheme Update
17th Aug 20202:45 pmRNSRestitution Scheme Update
11th Aug 20207:00 amRNSPublication of Annual Report and Notice of AGM
11th Aug 20207:00 amRNSRestitution Scheme Update
29th Jul 20207:00 amRNSIssue of Equity and Total Voting Rights
21st Jul 20207:00 amRNSPreliminary Results Announcement FY20
13th Jul 20201:19 pmRNSGeneral Meeting Result, Voting Rights & Admission
26th Jun 202010:07 amRNSAdditional Voting Support
26th Jun 20207:00 amRNSProposed Restitution Scheme and Placing
26th Jun 20207:00 amRNSTrading Update and Results Date
19th Jun 20207:00 amRNSDelay of Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.